ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Heart Disease, Ischemic
IJCS
Editorial

Atrial Fibrillation and Hemodialysis – Should we Anticoagulate These Patients? Ischemic Versus Hemorrhagic Risk

Iara Atié Malan

Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide, and it is a very frequent cause of increased morbidity and mortality in adults. This arrhythmia favors the formation of thrombi, which can lead to systemic embolism, such as ischemic stroke.

To identify patients with thromboembolic risk, the most used score is the CHA2DS2VASC, which takes the following factors in consideration: heart failure, arterial hypertension, age, diabetes, previous stroke, vascular disease, and sex. It is worth emphasizing that this score does not take renal function or dialysis treatment into consideration.

[…]

  • Anticoagulants
  • Atrial Fibrillation
  • Heart Disease, Ischemic
  • Hemorrhage
  • renal dialysis
  • Stroke
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
28/11/2022 DOI: 10.36660/ijcs.20220171

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Malan IA. Atrial Fibrillation and Hemodialysis – Should we Anticoagulate These Patients? Ischemic Versus Hemorrhagic Risk. International Journal of Cardiovascular Sciences 2022;35(6):757-9.

Electronic Document Format (ABNT)

Malan, Iara Atié. Atrial Fibrillation and Hemodialysis – Should we Anticoagulate These Patients? Ischemic Versus Hemorrhagic Risk. International Journal of Cardiovascular Sciences, v. 35, n. 6, p. 757-759, Nov. 2022.

Electronic Document Format (APA)

Malan, I. A. (2022). Atrial Fibrillation and Hemodialysis – Should we Anticoagulate These Patients? Ischemic Versus Hemorrhagic Risk. International Journal of Cardiovascular Sciences, 35(6), 757-759.

Electronic Document Format (ISO)

Malan, Iara Atié. Atrial Fibrillation and Hemodialysis – Should we Anticoagulate These Patients? Ischemic Versus Hemorrhagic Risk. International Journal of Cardiovascular Sciences [online]. 2022, vol. 35, n. 6, [cited 2026-10-14], pp. 757-759. Available from: <https://journals.cardiol.br/en/article/atrial-fibrillation-and-hemodialysis-should-we-anticoagulate-these-patients-ischemic-versus-hemorrhagic-risk/>. ISSN 2359-4802

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News